Gene · 910
Papers2,023
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,023
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD1b Tetramers Broadly Detect T Cells That Correlate With Mycobacterial Exposure but Not Tuberculosis Disease State. | Front Immunol | 2020 | 32117314 | PubTator, text mining | PubMed |
| T Cell Responses to Mycobacterial Glycolipids: On the Spectrum of "Innateness". | Front Immunol | 2020 | 32117300 | PubTator, text mining | PubMed |
| Dissection of the Human T-Cell Receptor γ Gene Repertoire in the Brain and Peripheral Blood Identifies Age- and Alzheimer's Disease-Associated Clonotype Profiles. | Front Immunol | 2020 | 32117220 | PubTator, text mining | PubMed |
| The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF-κB axis. | Mol Biol Rep | 2020 | 32088816 | PubTator, text mining | PubMed |
| Human unconventional T cells in Plasmodium falciparum infection. | Semin Immunopathol | 2020 | 32076813 | PubTator, text mining | PubMed |
| Endoplasmic Reticulum-Associated Degradation-Dependent Processing in Cross-Presentation and Its Potential for Dendritic Cell Vaccinations: A Review. | Pharmaceutics | 2020 | 32070016 | PubTator, text mining | PubMed |
| Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment. | Cells | 2020 | 32069815 | PubTator, text mining | PubMed |
| Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6. | Bioorg Med Chem Lett | 2020 | 32067866 | PubTator, text mining | PubMed |
| Total Synthesis of a Mycolic Acid from Mycobacterium tuberculosis. | Angew Chem Int Ed Engl | 2020 | 32067294 | PubTator, text mining | PubMed |
| Modified cyclodextrins as broad-spectrum antivirals. | Sci Adv | 2020 | 32064341 | PubTator, text mining | PubMed |
| Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis. | Cell Death Differ | 2020 | 32042099 | PubTator, text mining | PubMed |
| The roles of autotaxin/lysophosphatidic acid in immune regulation and asthma. | Biochim Biophys Acta Mol Cell Biol Lipids | 2020 | 32004685 | PubTator, text mining | PubMed |
| Murine sca1/flk1-positive cells are not endothelial progenitor cells, but B2 lymphocytes. | Basic Res Cardiol | 2020 | 31980946 | PubTator, text mining | PubMed |
| Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments. | Cancers (Basel) | 2020 | 31979136 | PubTator, text mining | PubMed |
| Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. | J Clin Immunol | 2020 | 31953710 | PubTator, text mining | PubMed |
| In the Absence of a TCR Signal IL-2/IL-12/18-Stimulated γδ T Cells Demonstrate Potent Anti-Tumoral Function Through Direct Killing and Senescence Induction in Cancer Cells. | Cancers (Basel) | 2020 | 31947966 | PubTator, text mining | PubMed |
| An Ancient, MHC-Linked, Nonclassical Class I Lineage in Cartilaginous Fish. | J Immunol | 2020 | 31932500 | PubTator, text mining | PubMed |
| Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer. | Cancer Res | 2020 | 31915130 | PubTator, text mining | PubMed |
| Human T cell response to CD1a and contact dermatitis allergens in botanical extracts and commercial skin care products. | Sci Immunol | 2020 | 31901073 | PubTator, text mining | PubMed |
| Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult. | Neuron | 2020 | 31899072 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/910/papers?page=32